<DOC>
	<DOCNO>NCT02915107</DOCNO>
	<brief_summary>The aim Danish Organization Randomized Trials Clinical Outcome ( SORT OUT ) IX STEMI OCT compare early vascular heal polymer-free Biolimus-eluting BIOFREEDOM stent biodegradable-polymer Sirolimus-eluting ORSIRO stent patient ST-segment elevation myocardial infarction ( STEMI ) treat primary percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>The SORT OUT IX STEMI OCT Trial</brief_title>
	<detailed_description>SORT OUT IX STEMI OCT randomize 1:1 study compare polymer-free Biolimus-eluting BIOFREEDOM stent biodegradable-polymer Sirolimus-eluting ORSIRO stent patient STEMI treat primary PCI . Vascular heal index ( uncovered stent strut , malapposed stent strut , maximal intima coverage accumulate extra-stent lumen volume ) assess optical coherence tomography ( OCT ) 1 month primary PCI . Patients enrol investigator randomly allocate treatment group diagnostic coronary angiography primary PCI . A web base Trial Partner randomization system use . OCT perform frequency-domain OPTIS OCT system Dragonflyâ„¢ Imaging Catheter index procedure 1 month .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Patients age 18 year STEMI , require treatment drugeluting stent . life expectancy le one year ; allergy aspirin , clopidogrel , ticagrelor , prasugral , biolimus sirolimus ; participation another randomize trial ; chronic renal disease ; inability provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>drug elute stent</keyword>
	<keyword>coronary vascular healing</keyword>
</DOC>